The San Diego-based company began rolling out the system in Spain, Belgium and Poland. It plans for a launch next week in the Netherlands, too. In some countries, the system replaces the previous-generation Dexcom One sensor.
ONE+ uses Dexcom’s established sensor design, with the company incorporating feedback from users and healthcare professionals to build it. The company said this ensured an easy-to-use, highly effective CGM experience for people treating type 1 or type 2 diabetes with insulin.
This version of the platform utilizes the latest-generation G7 sensor, while the previous version used the G6. CEO Kevin Sayer told Drug Delivery Business News last month that he expected to complete this transfer during the first quarter of 2024.
ONE+ also adds certain notes at certain moments, like meals, insulin administration and sports activities. The system replaces the traditional fingersticks to provide a clear picture of how daily choices affect glucose levels.
“Dexcom ONE+ incorporates our best-in-class technology and a range of features that we know will be well-received by the diabetes community,” said Teri Lawver, Dexcom EVP and CCO. “By building Dexcom ONE+ based on user and healthcare professional feedback we know we have a CGM system that is flexible, easy to get started with, and intuitive to use; a system that people with either type 1 or type 2 diabetes, and their care teams, can benefit from.”
Other features of Dexcom ONE+
Dexcom designed the ONE+ platform to take away some of the burden of living with diabetes daily. In addition to providing glucose readings to users, it allows them to easily share their data with up to 10 people.
Features include multiple options for personalization and flexibility. It offers discretion, with three wear location options. Additionally, the CGM provides a “delay first high” option. This customizable feature allows users to set a time before which their sensor won’t alert them to a “high” glucose reading. That helps avoid alert fatigue. The waterproof device also allows users to continue wearing the CGM while showering or exercising.
Dexcom plans to announce further availability in Europe, the Middle East and Africa (EMEA) in the coming months.
“Dexcom ONE+ continues the work of Dexcom ONE in bringing access to our life-changing technology to millions of people across Europe, the Middle East and Africa,” said Alex Moussa, SVP and GM for Dexcom EMEA & LATAM. “Through our ongoing innovation and product development, not only are we bringing the best, and most accurate, version of our technology to even more people, but we continue to show our commitment to significantly expanding access to CGM for people with all types of diabetes.”
